Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator.
Van Den Broeck T, Stevenaert F, Taveirne S, Debacker V, Vangestel C, Vandekerckhove B, Taghon T, Matthys P, Plum J, Held W, Dewerchin M, Yokoyama WM, Leclercq G. Van Den Broeck T, et al. Among authors: vangestel c. Blood. 2008 Dec 15;112(13):5046-51. doi: 10.1182/blood-2008-06-164350. Epub 2008 Sep 10. Blood. 2008. PMID: 18784372 Free article.
Forcing cancer cells to commit suicide.
Vangestel C, Van de Wiele C, Mees G, Peeters M. Vangestel C, et al. Cancer Biother Radiopharm. 2009 Aug;24(4):395-407. doi: 10.1089/cbr.2008.0598. Cancer Biother Radiopharm. 2009. PMID: 19694574 Review.
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.
Jacobs J, Deschoolmeester V, Rolfo C, Zwaenepoel K, Van den Bossche J, Deben C, Silence K, de Haard H, Hermans C, Rottey S, Vangestel C, Lardon F, Smits E, Pauwels P. Jacobs J, et al. Among authors: vangestel c. Oncotarget. 2017 May 23;8(43):74058-74067. doi: 10.18632/oncotarget.18202. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088768 Free PMC article.
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
Maggi A, Ruivo E, Fissers J, Vangestel C, Chatterjee S, Joossens J, Sobott F, Staelens S, Stroobants S, Van Der Veken P, Wyffels L, Augustyns K. Maggi A, et al. Among authors: vangestel c. Org Biomol Chem. 2016 Aug 21;14(31):7544-51. doi: 10.1039/c6ob01411a. Epub 2016 Jul 19. Org Biomol Chem. 2016. PMID: 27431745
70 results